| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/13/1993 | WO1993008807A1 Phospholipid antimicrobial compositions |
| 05/13/1993 | WO1993008799A1 Endothelin receptor antagonists |
| 05/13/1993 | DE4136553A1 Impfstoff gegen schleimhauterreger und herstellungsverfahren Vaccine against pathogen mucosa and manufacturing processes |
| 05/13/1993 | CA2122820A1 Endothelin receptor antagonists |
| 05/13/1993 | CA2122263A1 Induction of protection against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein |
| 05/13/1993 | CA2122024A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/13/1993 | CA2082552A1 Process for the preparation of carbacyclic nucleosides, and intermediates |
| 05/13/1993 | CA2082107A1 Girondalones |
| 05/12/1993 | EP0541214A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 05/12/1993 | EP0541168A1 HIV protease inhibitors useful for the treatment of aids |
| 05/12/1993 | EP0541058A1 Expression of a mature proteinase 2a, its partial purification and preparation of inhibitory active substrates |
| 05/12/1993 | EP0540686A1 2'-fluorofuranosyl derivatives and novel method of preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides. |
| 05/12/1993 | EP0540645A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 05/12/1993 | EP0540609A1 Cephalosporins and homologues, preparations and pharmaceutical compositions |
| 05/12/1993 | EP0540606A1 Cephalosporins and homologues, preparations and pharmaceutical compositions |
| 05/12/1993 | EP0540525A1 Method of preparation of vaccines, and the use of the vaccines thus prepared |
| 05/12/1993 | CN1071952A 抗真菌剂 Antifungal agents |
| 05/12/1993 | CN1071930A Inhibitors of hiv protease useful for treatment of aids |
| 05/12/1993 | CA2082472A1 Crystalline form of a cephalosporin antibiotic |
| 05/11/1993 | US5210224 Process for preparing lankacidin carbamate derivatives |
| 05/11/1993 | US5210085 Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds |
| 05/11/1993 | CA1317594C Aminomethyloxooxazolidinyl ethenylbenzene derivatives useful as antibacterial agents |
| 05/11/1993 | CA1317542C Glutaraldehyde-based sterilising composition of antibacterial and antimycotic activity, in an aqueous vehicle |
| 05/10/1993 | CA2082446A1 Alkoxylated phenyl and coumarin derivatives useful in the treatment of viral infections |
| 05/07/1993 | CA2082217A1 Expression of mature proteinase 2a, the partial purification thereof and preparation of substrates having an inhibitory effect |
| 05/05/1993 | EP0540143A2 Compounds and methods for inhibition of HIV and related viruses |
| 05/05/1993 | EP0540135A2 Attenuated measles vaccine virus strain containing specific nucleotide sequence and a method for its absolute identification |
| 05/05/1993 | EP0540063A1 Hyperimmune serum for endotoxin associated disease, detoxified endotoxin and bacterial mutant |
| 05/05/1993 | EP0539938A1 Tri-substituted tetrahydrofuran antifungals |
| 05/05/1993 | EP0539651A1 Dentifrice containing antibacterial material |
| 05/05/1993 | EP0539587A1 Antiretroviral agent |
| 05/05/1993 | EP0539522A1 Improved immunotherapeutic method of preventing or treating viral respiratory tract disease |
| 05/05/1993 | EP0539516A1 Asphodelus composition for increasing white blood cell count |
| 05/05/1993 | EP0539506A1 Method for treating viral infections using oxidized lipoproteins |
| 05/05/1993 | EP0539492A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
| 05/05/1993 | EP0539487A1 Antiviral phosphono-alken derivatives of purines |
| 05/05/1993 | EP0539457A1 Compositions based on active principles of hydrophobic medicaments solubilizable in an aqueous solvent |
| 05/05/1993 | EP0539451A1 Vinylsulphonyl pristinamycin and preparation thereof. |
| 05/05/1993 | EP0539442A1 Enzyme inactivators |
| 05/05/1993 | CN1071668A Anti-endotoxin compounds |
| 05/05/1993 | CN1020407C Process for preparation of influenze vaccine |
| 05/04/1993 | US5208321 Labeled antigens |
| 05/04/1993 | US5208221 Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives |
| 05/04/1993 | US5208159 Antibacterial, anti-nematode and/or plant-cell activating composition, and chitinolytic microorganisms for producing the same |
| 05/04/1993 | US5208015 Topical anti-fungal agents having anti-inflammatory activity |
| 05/04/1993 | CA1317302C N-1 substituted .beta.-lactams as antibiotics |
| 05/04/1993 | CA1317298C Antibiotic sulfonylaminocarbonyl activated .beta.-lactams |
| 05/04/1993 | CA1317288C Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 05/04/1993 | CA1317224C Method and composition for the treatment and prevention of viral infections |
| 05/01/1993 | WO1993008844A1 Transformant cells for the prophylaxis or treatment of diseases caused by viruses, particularly pathogenic retroviruses |
| 05/01/1993 | CA2099247A1 Transformant cells for the prophylaxis or treatment of diseases caused by viruses, particularly pathogenic retroviruses |
| 05/01/1993 | CA2081674A1 Heterocyclic compounds |
| 04/30/1993 | CA2081510A1 Alkaloids and processes for their production |
| 04/30/1993 | CA2065882A1 Dentifrice containing antibacterial material |
| 04/29/1993 | WO1993008299A1 Preparation of recombinant borrelia proteins |
| 04/29/1993 | WO1993008286A1 VIRULENCE ASSOCIATED PROTEINS IN BORRELIA BURGDORFERI (Bb) |
| 04/29/1993 | WO1993008283A1 Vaccines for actinobacillus pleuropneumoniae |
| 04/29/1993 | WO1993008215A1 Secreted mac-2-binding glycoprotein |
| 04/29/1993 | WO1993008209A1 Diagnosis and treatment of bacterial dysentery |
| 04/29/1993 | WO1993008195A1 Cyclic peroxyacetal compounds |
| 04/29/1993 | WO1993008184A1 Hiv protease inhibitors |
| 04/29/1993 | WO1993007898A1 Porcine reproductive respiratory syndrome vaccine and diagnostic |
| 04/29/1993 | WO1993007897A1 Bacterial expression vectors containing dna encoding secretion signals of lipoproteins |
| 04/29/1993 | WO1993007894A1 Dermatomycosis vaccine |
| 04/29/1993 | WO1993007868A1 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-tumor and anti-retroviral agents |
| 04/29/1993 | WO1993007856A1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
| 04/29/1993 | WO1993007747A1 Antimicrobial dialdehyde composition and methods of use |
| 04/29/1993 | WO1993000365A3 Hepatitis c virus (hcv) polypeptides |
| 04/29/1993 | CA2121900A1 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-tumor and anti-retroviral agents |
| 04/29/1993 | CA2121493A1 Bacterial expression vectors containing dna encoding secretion signals of lipoproteins |
| 04/29/1993 | CA2120050A1 Virulence associated proteins in borrelia burgdorferi (bb) |
| 04/28/1993 | EP0539329A1 Acetenyl compounds useful as leukotrien antagonists |
| 04/28/1993 | EP0539319A2 Pharmaceutical cyclosporin composition |
| 04/28/1993 | EP0539204A1 Antiviral 4-substituted-2-deoxy-2,3-didehydro derivatives of alpha D-neuraminic acid |
| 04/28/1993 | EP0539192A1 HIV Protease inhibitors |
| 04/28/1993 | EP0539180A1 Antiviral agents |
| 04/28/1993 | EP0539088A1 Echinocandin b derivative |
| 04/28/1993 | EP0538692A1 Use of partly known substituted pyrrolidine derivatives as pharmaceuticals, new compounds and process for their preparation |
| 04/28/1993 | EP0538691A1 Substituted tetrahydrothiophenes, methods for their preparation, and their use in pharmaceutical compositions |
| 04/28/1993 | EP0538689A1 Substituted 2,3-dihydropyrans, method for their preparation and their use as medicaments |
| 04/28/1993 | EP0538688A1 Substituted tetrahydrofurans, methods for their preparation, and their use as pharmaceutical compositions |
| 04/28/1993 | EP0538496A1 Recombinant fowlpox virus with intact FPV-tk-gene |
| 04/28/1993 | EP0538486A1 Sewing machine needle and method of manufacturing same |
| 04/28/1993 | EP0538463A1 Novel biologically active peptide compositions and uses therefor |
| 04/28/1993 | EP0538437A1 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
| 04/28/1993 | EP0538404A1 Fibroblast growth factor receptors |
| 04/28/1993 | EP0538396A1 Inhibitors of retroviral proteases |
| 04/28/1993 | EP0538383A1 Inhibitors of aspartic proteases |
| 04/28/1993 | EP0538374A1 Aspartic protease inhibitors |
| 04/28/1993 | EP0538373A1 Anti-herpes virus and cytomegalovirus oligomers |
| 04/28/1993 | EP0538366A1 Retroviral protease inhibitors |
| 04/28/1993 | EP0538318A1 Production of outer membrane (om) proteins in gram-positive bacteria and recovery of protective epitopes |
| 04/28/1993 | EP0538300A1 O-glycosylated ifn-alpha. |
| 04/28/1993 | EP0538299A1 Equine herpesvirus-4 tk?- vaccine |
| 04/28/1993 | EP0538297A1 Antiviral tetrahydroimidazo 1,4]benzodiazepin-2-(thio)ones |
| 04/28/1993 | CN1071428A Pyrroliaylthiocarbapenem derivatives |
| 04/28/1993 | CN1071415A Novel 9-amino-7-substituted-6-demethyl-6-deoxytetracyclines |
| 04/27/1993 | US5206251 Viricide |
| 04/27/1993 | US5206008 Using androstene(diol or triol) |
| 04/27/1993 | CA1316929C Method of inhibiting virus |